Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition – implications for the next generation of DC vaccines-Reference-Cited by-同舟云学术

Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition – implications for the next generation of DC vaccines

Published:2019-04-13 Issue:7 Volume:8 Page:e1593803
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Adhikaree Jason¹,Franks Hester Ann¹^ORCID,Televantos Constantinos¹,Vaghela Poonam¹,Kaur Aanchal Preet¹,Walker David²^ORCID,Schmitz Marc³⁴⁵⁶,Jackson Andrew Mark¹,Patel Poulam Manubhai¹^ORCID

Affiliation:

1. Division of Cancer and Stem Cells, Host-Tumour Interactions Group, UK

2. Children’s Brain Tumour Research Centre, University of Nottingham, Nottingham, UK

3. Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany

4. National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany

5. German Cancer Consortium (DKTK), Dresden, Germany

6. German Cancer Research Center (DKFZ), Heidelberg, Germany

Funder

Cancer Research UK

Medical Research Council

National Institutes for Health Research

Wellcome Trust